PRESS RELEASE
News
-
-
PRESS RELEASE
Successful Holding of UniCom International Technology Conference in Hong Kong: Announcing the Establishment of Hong Kong Innovation Research Institute and Refreshing International Brand
China Unicom (Hong Kong) successfully holds UniCom International Technology Conference in Hong Kong, unveils Innovation Research Institute, and refreshes international brand -
PRESS RELEASE
Crossject et le Département américain de la Défense relancent leur coopération en matière de recherche sur les auto-injecteurs sans aiguille en reconduisant leur accord de coopération en R&D
Crossject et le Département américain de la Défense relancent leur coopération en recherche sur les auto-injecteurs sans aiguille en reconduisant leur accord de coopération en R&D -
PRESS RELEASE
Inside Information / News release on accounts, results
Poxel reports financial results for first half 2024 including revenue of EUR 1.162 million and net loss of EUR 7.258 million, provides outlook following non-adoption of financial delegations at AGM, upcoming General Meeting to adopt new resolutions -
PRESS RELEASE
Crossject and the U.S. Department of Defense Relaunch Joint Research on Needle-free Autoinjectors, Extending Their Cooperative Research and Development Agreement
Crossject and the U.S. Department of Defense extend their cooperative research on needle-free autoinjectors, aiming to provide life-saving treatment in extreme conditions -
-
-
-
REGULATED PRESS RELEASE
BIOFIRE® FILMARRAY® Tropical Fever Panel, a syndromic PCR test targeting causes of tropical fever infections, receives U.S. FDA Special 510(k) clearance
bioMérieux receives U.S. FDA Special 510(k) clearance for BIOFIRE® FILMARRAY® Tropical Fever Panel, an innovative PCR test identifying tropical fever pathogens for optimized treatment -
REGULATED PRESS RELEASE
BIOFIRE® FILMARRAY® Tropical Fever Panel, un test PCR pour détecter l’origine des fièvres tropicales, obtient l’autorisation spéciale 510(k) de la FDA américaine
Le test PCR BIOFIRE® FILMARRAY® Tropical Fever obtient l’autorisation spéciale 510(k) de la FDA pour détecter les fièvres tropicales. Un outil innovant pour un diagnostic précis et rapide
